Mycobacterium chelonae empyema in an immunocompetent patient

Journal of Medical Microbiology

Volumn 57, Issue 5, 2008, Pages 664-667

  Hsieh, Hsiao Cheng ^a,b   Lu, Po Liang ^a,c   Chen, Tun Chieh ^a,c   Chang, Ko ^a,b   Chen, Yen Hsu ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; RIFAMPICIN;

ADULT; ARTICLE; BRONCHOPLEURAL FISTULA; CASE REPORT; COUGHING; DECORTICATION; EMPYEMA; FEMALE; FEVER; HUMAN; IMMUNOCOMPROMISED PATIENT; LUNG TUBERCULOSIS; MYCOBACTERIUM CHELONEI; PRIORITY JOURNAL; PUS; SPUTUM; THORACOTOMY;

ANTITUBERCULAR AGENTS; EMPYEMA, PLEURAL; FEMALE; HUMANS; IMMUNOCOMPETENCE; MIDDLE AGED; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, ATYPICAL; SPUTUM;

EID: 43049135568     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47574-0     Document Type: Article

References (20)

1. American Thoracic Society (1997). Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156, S1-S25.
2. Aronchick, J. M., Miller, W. T., Epstein, D. M. & Gefter, W. B. (1986). Association of achalasia and pulmonary Mycobacterium fortuitum infection. Radiology 160, 85-86.
3. Brown-Elliott, B. A. & Wallace, R. J., Jr (2002). Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 15, 716-746.
4. Chalermskulrat, W., Gilbey, J. G. & Donohue, J. F. (2002). Nontuberculous mycobacteria in women, young and old. Clin Chest Med 23, 675-686.
5. Dalovisio, J. R., Pankey, G. A., Wallace, R. J. & Jones, D. B. (1981). Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei. Rev Infect Dis 3, 1068-1074.
6. Driscoll, M. S. & Tyring, S. K. (1997). Development of resistance to clarithromycin after treatment of cutaneous Mycobacterium chelonae infection. J Am Acad Dermatol 36, 495-496.
7. Fairhurst, R. M., Kubak, B. M., Shpiner, R. B., Levine, M. S., Pegues, D. A. & Ardehali, A. (2002). Mycobacterium abscessus empyema in a lung transplant recipient. J Heart Lung Transplant 21, 391-394.
8. Franck, N., Cabie, A., Villette, B., Amor, B., Lessana-Leibowitch, M. & Escande, J. P. (1993). Treatment of Mycobacterium chelonae-induced skin infection with clarithromycin. J Am Acad Dermatol 28, 1019-1021.
9. Griffith, D. E., Girard, W. M. & Wallace, R. J., Jr (1993). Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis 147, 1271-1278.
10. Hazelton, T. R., Newell, J. D., Cook, J. L., Huitt, G. A. & Lynch, D. A. (2000). CT findings in 14 patients with Mycobacterium chelonae pulmonary infection. AJR Am J Roentgenol 175, 413-416.
11. Kressel, A. B. & Kidd, F. (2001). Pseudo-outbreak of Mycobacterium chelonae and Methylobacterium mesophilicum caused by contamination of an automated endoscopy washer. Infect Control Hosp Epidemiol 22, 414-418.
12. McFarland, E. J. & Kuritzkes, D. R. (1993). Clinical features and treatment of infection due to Mycobacterium fortuitum/chelonae complex. Curr Clin Top Infect Dis 13, 188-202.
13. Mushatt, D. M. & Witzig, R. S. (1995). Successful treatment of Mycobacterium abscessus infections with multidrug regimens containing clarithromycin. Clin Infect Dis 20, 1441-1442.
14. Telenti, A., Marchesi, F., Balz, M., Bally, F., Böttger, E. C. & Bodmer, T. (1993). Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 31, 175-178.
15. Wallace, R. J., Jr, Swenson, J. M., Silcox, V. A., Good, R. C., Tschen, J. A. & Stone, M. S. (1983). Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 5, 657-679.
16. Wallace, R. J., Jr, Brown, B. A. & Onyi, G. O. (1992). Skin, soft tissue and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 166, 405-412.
17. Wallace, R. J., Jr, Tanner, D., Brennan, P. J. & Brown, B. A. (1993). Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann Intern Med 119, 482-486.
18. Yang, S. C., Hsueh, P. R., Lai, H. C., Teng, L. J., Huang, L. M., Chen, J. M., Wang, S. K., Shie, D. C., Ho, S. W. & Luh, K. T. (2003). High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrob Agents Chemother 47, 1958-1962.
19. Zahid, M. A., Klotz, S. A., Goldstein, E. & Bartholomew, W. (1994). Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin. Clin Infect Dis 18, 999-1001.
20. Zaleznik, D. F. & Quinn, T. R. (1996). Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-1996 - a 55-year-old man with a long-term tracheostomy and acid-fast bacilli in peristomal granulations. N Engl J Med 335, 1303-1307.